STOCKHOLM, Sweden, Aug. 2, 2005 (PRIMEZONE) -- Artimplant, the Swedish biomaterials company, appoints Lars-Johan Cederbrant as Chief Financial Officer.
Mr. Cederbrant will assume his new responsibility during August 2005. Lars-Johan Cederbrant has previously served as CEO of CardioBridge GmbH and as CFO during the reconstruction of Jomed N.V.
"His experience from the medical technology industry and from business development helps to strengthen the Company as we expand on our biomaterial platform Artelon(R)," stated CEO Tord Lendau.
Artimplant's mission is to develop novel biodegradable materials and implants that meet the needs of patients, physicians and healthcare providers in orthopedics and other therapy areas. The company works together with global partners as a center of excellence in this development. Artimplant's vision is to become the partner of choice in biomaterials for hard and soft tissue repair in multiple therapy areas. Artimplant is a public company, listed on the Stockholm Exchange, O-list.
This information was brought to you by Waymaker http://www.waymaker.net
The following files are available for download:
http://wpy.waymaker.net/client/waymaker1/WOLReleaseFile.aspx?id=119116&fn=wkr0001.pdf